Table 1.

Patient characteristics of primary AML patient samples

Patients	Gender	Age (years)	Disease status	FAB subtype	Cytogenetics	Blast purity (%)	Gene mutation
AML#196	Female	40	Newly diagnosed	M5	46, XX	98.00	NPM1, FLT3-ITD, DNMT3A
AML#198	Female	44	Newly diagnosed	M2	46, XX, t(8;21)(q22;q22)	68.00	ASXL1, K-RAS, N-RAS
AML#200	Male	44	Newly diagnosed	M2	46, XY	77.00	CEBPAdm, FLT3-ITD
AML#203	Female	13	Newly diagnosed	M3	NA	NA	NA
AML#205	Female	61	Newly diagnosed	M3	46, XX, t(15;17): (q22;q21)	90.15	PML-RARα, ATRX, FLT3-ITD
AML#206	Male	36	Newly diagnosed	M1	46, XY	90.50	DNMT3A, IDH2, NPM1

NA not available